Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors

Chromosomal fusions encoding novel molecular drivers have been identified in several solid tumors, and in recent years the identification of such pathogenetic events in tumor specimens has become clinically actionable. Pediatric sarcomas and other rare tumors that occur in children as well as adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Wen-I, Lin, Claire, Liguori, Nicholas, Honeyman, Joshua N., DeNardo, Bradley, El-Deiry, Wafik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811504/
https://www.ncbi.nlm.nih.gov/pubmed/35126101
http://dx.doi.org/10.3389/fphar.2021.747895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811504/
https://www.ncbi.nlm.nih.gov/pubmed/35126101
http://dx.doi.org/10.3389/fphar.2021.747895

Ejemplares similares